These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Mechanisms of intravenous immunoglobulin action in the treatment of autoimmune disorders. Larroche C; Chanseaud Y; Garcia de la Pena-Lefebvre P; Mouthon L BioDrugs; 2002; 16(1):47-55. PubMed ID: 11909001 [TBL] [Abstract][Full Text] [Related]
4. [Indications and mechanisms of action of the intravenous immunoglobulines in the systemic autoimmune and inflammatory pathologies]. Mouthon L; Bussone G; Kaveri S Rev Med Interne; 2009 Dec; 30(12 Suppl):H14-20. PubMed ID: 19995651 [TBL] [Abstract][Full Text] [Related]
5. [The rational immunotherapy with intravenous immunoglobulin in neurologic diseases]. Korsak J Pol Merkur Lekarski; 2011 Jun; 30(180):430-4. PubMed ID: 21751554 [TBL] [Abstract][Full Text] [Related]
10. Immunomodulatory effects of intravenous immunoglobulins as a treatment for autoimmune diseases, cancer, and recurrent pregnancy loss. Sapir T; Blank M; Shoenfeld Y Ann N Y Acad Sci; 2005 Jun; 1051():743-78. PubMed ID: 16127014 [TBL] [Abstract][Full Text] [Related]
16. Complement deposition induced by binding of anti-contactin-1 auto-antibodies is modified by immunoglobulins. Appeltshauser L; Weishaupt A; Sommer C; Doppler K Exp Neurol; 2017 Jan; 287(Pt 1):84-90. PubMed ID: 27746185 [TBL] [Abstract][Full Text] [Related]
17. The IgG molecule as a biological immune response modifier: mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders. Ballow M J Allergy Clin Immunol; 2011 Feb; 127(2):315-23; quiz 324-5. PubMed ID: 21185071 [TBL] [Abstract][Full Text] [Related]
18. [Mechanisms of action of intravenous immunoglobulins in the treatment of autoimmune diseases]. Mouthon L; Hurez V; Kazatchkine M Ann Med Interne (Paris); 1993; 144(8):506-13. PubMed ID: 8179238 [TBL] [Abstract][Full Text] [Related]
19. Mechanisms of action of intravenous immunoglobulins. Baerenwaldt A; Biburger M; Nimmerjahn F Expert Rev Clin Immunol; 2010 May; 6(3):425-34. PubMed ID: 20441428 [TBL] [Abstract][Full Text] [Related]
20. [Indications for immunoglobulins. Recommendations of CEDIT of AP-HP in 2006]. Guillevin L Rev Med Interne; 2007 May; 28 Spec No. 1():1-3. PubMed ID: 17768830 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]